Delivery Order SPE2DR25D1052-SPE2DR26F6CC7
Award Date 11/18/25
Potential Completion Date 11/19/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,946.55 to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye DR 100s. This is a firm fixed price, non-set-aside contract awarded on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $9,735.52 to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye DR 100s on July 24, 2025, with completion expected by July 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement for federal medical needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 units of PERTZYE DR 100S capsules, with a firm fixed price ceiling value of $24,368.76. The ultimate completion date for this delivery order is May 27, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for 16,000 units of PERTZYE DR, a prescription medication, with a potential value of $5,826.78 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, and it is not designated as a...
- This federal contract award is for the delivery of 16,000 units of the medication PERTZYE DR 16,000 UNIT CAPSULE to the Defense Logistics Agency (DLA), a defense agency. The $26,094.23 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 13, 2024, with a completion date of March 14, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- The Defense Logistics Agency awarded a $4,464.24 firm fixed price delivery order to AmerisourceBergen Drug Corp for 24,000 unit capsules of Pertzye on June 9, 2025, with an ultimate completion date of June 10, 2025. This non-set-aside contract represents a routine pharmaceutical supply delivery executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pertzye (pancrelipase) capsules, 16,000 units at 100s strength, with a contract value of $44,349.27. This is a firm fixed price delivery order with an ultimate completion date of June 11, 2025, issued on June 10, 2025. The award was made through open competition with no set-aside designation. Performance will be conducted at the contractor's corporate office location in Conshohocken,...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $8,136.80 with a firm fixed price for the delivery of 24,000 units of the medication PERTZYE DR 80S capsule. The contract has an ultimate completion date of July 18, 2025 and was awarded on July 17, 2025. This contract award is not designated as a set-aside....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,242.46, is for the delivery of 24,000 units of the prescription medication PERTZYE DR 80S. The contract is a firm fixed-price, non-set-aside award with a performance period through July 2025. Amerisourcebergen also holds a significant Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $4,046.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye DR 100s, a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency. The award, issued on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing contract vehicle. Performance will be executed at the company's corporate office location in...